Physician profile
Manfred C Chiang
NPI 1770563868
$109,991.35
in general payments reported to CMS, 2019-2025
8 companies · $1,510 in 2025
The $1,510 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $40K · 2021: $19K · 2022: $12K · 2023: $18K · 2024: $18K · 2025: $1,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $32K · Travel and Lodging: $2,739 · Food and Beverage: $2,232 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $32,000.00 |
| Travel and Lodging | $2,738.74 |
| Food and Beverage | $2,231.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $109,250.45 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $394.45 | 2021-2022 | |
| Allergan, INC. | $124.96 | 2019 | |
| Baxter Healthcare | $90.05 | 2024 | Perclot |
| Ethicon US, LLC | $83.65 | 2019-2025 | Echelon Endopath |
| Teleflex LLC | $20.10 | 2025 | Titan Sgs Bailout Chuck |
| Endogastric Solutions, INC | $15.76 | 2019 | |
| Covidien LP | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manfred Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.